NCT02276716View on ClinicalTrials.gov

The Nutritional Supplement Phosphatidylserine in Patients With Familial Dysautonomia

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

August 1, 2019

Study Completion Date

August 1, 2019

Conditions
Familial Dysautonomia
Interventions
DIETARY_SUPPLEMENT

Phosphatidylserine

Phosphatidylserine will be titrated starting at 300mg/day dose for two months to 600mg/day dose for 2 months, then 800 mg/day dose for a final 2 month period.

Trial Locations (1)

10016

NYU Langone Medical Center, Dyautonomia Center, Suite 9Q, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT02276716 - The Nutritional Supplement Phosphatidylserine in Patients With Familial Dysautonomia | Biotech Hunter | Biotech Hunter